Clinical Research Directory
Browse clinical research sites, groups, and studies.
Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia
Sponsor: University of Rochester
Summary
This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and improves patient-centered outcomes compared with usual oncologist-directed care in adults aged 60 years and older with newly diagnosed AML.
Official title: Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia (The ALIGN-AML Trial)
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-12-01
Completion Date
2031-11-30
Last Updated
2026-07-29
Healthy Volunteers
No
Conditions
Interventions
GA-directed treatment regimens
Fit, vulnerable, and frail patients will receive predefined regimens based on their GA results.
Locations (1)
University of Rochester Medicine
Rochester, New York, United States